ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial
Product details
Registration number: SIN14532P
Classification: Prescription Only
Active ingredients: Paclitaxel
Strength: 100mg/vial
Dosage form: INJECTION, POWDER, FOR SUSPENSION
Route: INTRAVENOUS DRIP
Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
ATC code: L01CD01
HSA approval date: 31 March 2014
Manufacturer(s):
- Abraxis BioScience, LLC
- Baxter Oncology GmbH
Manufacturing country/countries: UNITED STATES; GERMANY
What are the HSA registration number and classification for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14532P
Classification: Prescription Only
What active ingredients and strength are recorded for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Paclitaxel
Strength: 100mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SUSPENSION
Route: INTRAVENOUS DRIP
Who is the recorded registrant for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Abraxis BioScience, LLC
- Baxter Oncology GmbH
Manufacturing country/countries: UNITED STATES; GERMANY
Where can I look up ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14532P or the exact product name ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial. The general register link does not preselect this product.
What are the source dates for this ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14532P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)